Authors: MEIKLE SR MATTHEWS JC BROCK CS WELLS P HARTE RJA CUNNINGHAM VJ JONES T PRICE P

Citation: Sr. Meikle et al., PHARMACOKINETIC ASSESSMENT OF NOVEL ANTICANCER DRUGS USING SPECTRAL-ANALYSIS AND POSITRON-EMISSION-TOMOGRAPHY - A FEASIBILITY STUDY, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 183-193

Authors: BRADY F LUTHRA SK BROWN G OSMAN S HARTE RJA DENNY WA BAGULEY BC JONES T PRICE PM

Citation: F. Brady et al., C-11 LABELING OF THE ANTITUMOR AGENT N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE (DACA) AND DETERMINATION OF PLASMA METABOLITES IN MAN, Applied radiation and isotopes, 48(4), 1997, pp. 487-492

Authors: OSMAN S LUTHRA SK BRADY F HUME SP BROWN G HARTE RJA MATTHEWS JC DENNY WA BAGULEY BC JONES T PRICE PM

Citation: S. Osman et al., STUDIES ON THE METABOLISM OF THE NOVEL ANTITUMOR AGENT 1]N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE IN RATS AND HUMANS PRIOR TO PHASE-I CLINICAL-TRIALS, Cancer research, 57(11), 1997, pp. 2172-2180

Authors: TILSLEY DWO HARTE RJA JONES T BRADY F LUTHRA SK BROWN G PRICE PM

Citation: Dwo. Tilsley et al., NEW TECHNIQUES IN THE PHARMACOKINETIC ANALYSIS OF CANCER DRUGS .4. POSITRON EMISSION TOMOGRAPHY, Cancer surveys, 17, 1993, pp. 425-442